Back to Search
Start Over
In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation.
- Source :
-
Journal of vascular surgery [J Vasc Surg] 2009 Nov; Vol. 50 (5), pp. 1063-70. Date of Electronic Publication: 2009 Aug 12. - Publication Year :
- 2009
-
Abstract
- Objective: As in arteries, venous endothelium modulates vessel homeostasis and tone. The effect of an arterialized environment on venous endothelial function remains poorly understood. In particular, regulation of saphenous vein graft (SVG) blood flow and lumen caliber remains undefined. We hypothesized that mature SVGs would exhibit endothelium-dependent, flow-mediated vasodilation (FMD). We further hypothesized that endothelium-derived nitric oxide (NO) was an important mediator.<br />Methods: Patients with femoral to popliteal artery SVGs that had maintained primary patency and were at least 1 year from surgery were enrolled. High-resolution, B-mode ultrasound scans were used to measure vein graft diameter before and 1 minute after reactive hyperemia (RH) to determine FMD. RH was created through application of 220 mm Hg to the calf for 5 minutes with a sphygmomanometric cuff. After a 10-minute recovery period, nitroglycerin-mediated, endothelium-independent vasodilation was measured 3 minutes after administration of nitroglycerin 0.4 mg sublingually. Brachial artery FMD was determined by validated techniques. L-N(G)monomethyl arginine (L-NMMA; 1 mg/kg infusion over 10 minutes) was used in a subset of patients (n = 6) to competitively inhibit endothelial NO synthase.<br />Results: Nineteen subjects were enrolled. The median age of the SVGs was 34.6 (21.0-49.7) months. SVG flow-mediated, endothelium-dependent vasodilation was measured at 5.28% +/- 3.1% mean change in lumen diameter (range, 1.99%-9.36%; P < .0001 for diameter change). Nitroglycerin-mediated vasodilation was 3.7% +/- 1.0%, (range, 16%-10.04%; P < .005). Intravenous administration of L-NMMA abolished SVG FMD (5.7 +/- 1.4% before L-NMMA vs 0.01 +/- 0.01% during L-NMMA infusion; P = .0088) and attenuated brachial artery FMD (7.54% +/- 1.0% vs 5.7 +/- 1.4; P = .05).<br />Conclusion: SVGs manifest flow-mediated, endothelium-dependent, and nitroglycerin-mediated endothelium-independent vasodilation. Vein graft endothelium-dependent FMD is likely mediated by NO. Further investigation will be required to determine the role of endothelial function in vein graft patency.
- Subjects :
- Administration, Oral
Brachial Artery diagnostic imaging
Brachial Artery physiopathology
Cohort Studies
Endothelium, Vascular drug effects
Endothelium, Vascular metabolism
Endothelium, Vascular pathology
Enzyme Inhibitors administration & dosage
Femoral Artery physiopathology
Humans
Hyperemia physiopathology
Infusions, Intravenous
Nitric Oxide metabolism
Nitric Oxide Synthase Type III antagonists & inhibitors
Nitric Oxide Synthase Type III metabolism
Nitroglycerin administration & dosage
Peripheral Vascular Diseases metabolism
Peripheral Vascular Diseases physiopathology
Popliteal Artery physiopathology
Regional Blood Flow
Saphenous Vein diagnostic imaging
Saphenous Vein drug effects
Saphenous Vein metabolism
Saphenous Vein physiopathology
Time Factors
Treatment Outcome
Ultrasonography, Doppler
Vasodilator Agents administration & dosage
omega-N-Methylarginine administration & dosage
Endothelium, Vascular transplantation
Femoral Artery surgery
Lower Extremity blood supply
Peripheral Vascular Diseases surgery
Popliteal Artery surgery
Saphenous Vein transplantation
Vascular Patency
Vasodilation
Subjects
Details
- Language :
- English
- ISSN :
- 1097-6809
- Volume :
- 50
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of vascular surgery
- Publication Type :
- Academic Journal
- Accession number :
- 19679424
- Full Text :
- https://doi.org/10.1016/j.jvs.2009.06.022